S. Alfediam, Guide pour la prise en charge du diabétique ägé-1ère édition-. Médecine Mal Métaboliques, Hors-série, vol.1, 2008.

P. T. Campbell, C. C. Newton, A. V. Patel, E. J. Jacobs, and S. M. Gapstur, Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care, vol.35, pp.1835-1844, 2012.

L. Mandereau-bruno, A. Fagot-campagna, G. Rey, C. Piffaretti, J. Antero-jacquemin et al., Surmortalité sur la période 2002-2011 des personnes diabétiques traitées pharmacologiquement en France métropolitaine par rapport à la population générale

, Bull Epidémiol Hebd, pp.676-680, 2001.

K. Ogurtsova, J. D. Da-rocha-fernandes, and Y. Huang, IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040, Diabetes Res Clin Pract, vol.128, pp.40-50, 2017.

, Monitoring health for the SDGs, WHO | World Health Statistics, 2016.

, Mortalité liée au diabète / Données épidémiologiques / Diabète / Maladies chroniques et traumatismes / Dossiers thématiques / Accueil, 2017.

I. Romon, E. Jougla, A. Weill, E. Eschwège, D. Simon et al., Description de la mortalité et des causes de décès dans une cohorte d'adultes diabétiques , en France métropolitaine-Étude Entred, Bull Epidémiol Hebd, pp.469-472, 2001.

A. Stokes and S. H. Preston, Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches, PLoS ONE, vol.12, issue.1, 2017.

G. Seematter, R. Chioléro, and L. Tappy, Métabolisme du glucose en situation physiologique. Httpwwwem-Premiumcomdatarevues07507658v28i5S0750765809001282, 2009.

J. Gautier and S. P. Choukem, Les incrétines, Nutr Clin Métabolisme, vol.22, issue.2, pp.59-65, 2008.

A. Hartemann and A. Grimaldi, Guide pratique du diabète, 2013.

P. Guillausseau and M. Laloi-michelin, Physiopathologie du diabète de type 2, Rev Médecine Interne, vol.24, issue.11, pp.730-737, 2003.

C. Magnan, Insuline et fonction pancréatique, Médecine Mal Métaboliques, vol.2, pp.130-136, 2008.

X. Hébuterne, A. E. Raynaud-simon, A. Vellas, and B. , Traité de nutrition de la personne âgée

, Springer Science & Business Media, 2009.

S. Kury-paulin, V. Cachot, A. Penfornis, and . Cétoacidose, HttpwwwemPremiumcomdatatraitesgn10-44617, 2007.

S. Borot, C. Kleinclauss, and A. Penfornis, Coma hyperosmolaire. HttpwwwemPremiumcomdatatraitesgn10-44618, 2007.

E. R. Seaquist, J. Anderson, and B. Childs, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society, Diabetes Care, vol.36, issue.5, pp.1384-1395, 2013.

S. R. Heller and P. E. Cryer, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes, vol.40, issue.2, pp.223-226, 1991.

N. H. White, D. A. Skor, P. E. Cryer, L. A. Levandoski, D. M. Bier et al., Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy, N Engl J Med, vol.308, issue.9, pp.485-491, 1983.

S. A. Amiel, T. Dixon, R. Mann, and K. Jameson, Hypoglycaemia in Type 2 diabetes, Diabet Med J Br Diabet Assoc, vol.25, issue.3, pp.245-254, 2008.

, Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration, Diabetologia, vol.50, issue.6, pp.1140-1147, 2007.

J. P. Bremer, K. Jauch-chara, M. Hallschmid, S. Schmid, and B. Schultes, Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes, Diabetes Care, vol.32, issue.8, pp.1513-1517, 2009.

M. S. Maurer, J. Burcham, and H. Cheng, Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility, J Gerontol A Biol Sci Med Sci, vol.60, issue.9, pp.1157-1162, 2005.

A. Nicolucci, B. Pintaudi, and M. C. Rossi, The social burden of hypoglycemia in the elderly, Acta Diabetol, vol.52, issue.4, pp.677-685, 2015.

D. Simon, P. De-pablos-velasco, and K. G. Parhofer, Hypoglycaemic episodes in patients with type 2 diabetes-risk factors and associations with patient-reported outcomes: The PANORAMA Study, Diabetes Metab, vol.41, issue.6, pp.470-479, 2015.

M. C. Riddle, Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, Circulation, vol.122, issue.8, pp.844-846, 2010.

A. J. Scheen, Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment, Evid Based Med, vol.20, issue.3, pp.115-115, 2015.

E. Y. Lee, S. Hwang, and Y. H. Lee, Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes, Yonsei Med J, vol.58, issue.2, pp.312-318, 2017.

M. Bodmer, C. Meier, S. Krähenbühl, S. S. Jick, and C. R. Meier, Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia, Diabetes Care, vol.31, issue.11, pp.2086-2091, 2008.

S. R. Salpeter, E. Greyber, G. A. Pasternak, and E. E. Salpeter, Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus, Cochrane Database Syst Rev, issue.4, p.2967, 2010.

T. D. Control and C. Group, The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, N Engl J Med, vol.329, issue.14, pp.977-986, 1993.

D. M. Nathan and D. Group, The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care, vol.37, pp.9-16, 2014.

P. Massin and E. Kaloustian, The elderly diabetic's eyes, Diabetes Metab, vol.33, issue.1, pp.4-9, 2007.

S. Baillif, Rétinopathie diabétique (en dehors de la maculopathie), 2016.

A. J. Sinclair, A. J. Bayer, A. J. Girling, and K. W. Woodhouse, Older adults, diabetes mellitus and visual acuity: a community-based case-control study, Age Ageing, vol.29, issue.4, pp.335-339, 2000.

S. Lemoine, F. Buron, J. Fauvel, and . Néphropathie, HttpwwwemPremiumcomdatatraitesgn10-40783, 2013.

, Le poids des complications liées au diabète en France en 2013. Synthèse et perspectives2015_34-35_1.pdf, vol.53, 2017.

P. Lozeron, Neuropathies chez les diabétiques. Httpwwwem-Premiumcomdatatraitesne1775572, 2016.

N. A. Visser, N. C. Notermans, R. Linssen, L. H. Van-den-berg, and A. Vrancken, Neurology, vol.84, issue.3, pp.259-264, 2015.

J. Partanen, L. Niskanen, J. Lehtinen, E. Mervaala, O. Siitonen et al., Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus, N Engl J Med, vol.333, issue.2, pp.89-94, 1995.

M. Harris, R. Eastman, and C. Cowie, Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care, vol.16, pp.1446-1452, 1993.

J. J. Van-netten, P. E. Price, and L. A. Lavery, Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review, Diabetes Metab Res Rev, vol.32, issue.1, pp.84-98, 2016.

D. Malgrange, Physiopathologie du pied diabétique. HttpwwwemPremiumcomdatarevues02488663002900S20873950X, 2008.

S. Fosse, S. A. Jacqueminet, H. Duplan, A. Hartemann-heurtier, H. Van et al., Incidence et caractéristiques des amputations des membres inférieurs chez les personnes diabétiques en France métropolitaine, Bull Epidemiol Hebd, issue.10, pp.71-73, 2003.

P. Lermusiaux, N. Ferreira-maldent, F. Maillot, and J. Guilmot, Angiopathies diabétiques. Httpwwwem-Premiumcomdatatraitesage19-37359, 2006.

, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, vol.375, issue.9733, pp.60484-60493, 2010.

I. Romon, G. Rey, and L. Mandereau-bruno, The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes-the 2001-2006 ENTRED cohort, Diabet Med J Br Diabet Assoc, vol.31, issue.8, pp.946-953, 2014.

F. Pistrosch, A. Natali, and M. Hanefeld, Is hyperglycemia a cardiovascular risk factor? Diabetes Care, vol.34, pp.128-131, 2011.

E. Selvin, S. Marinopoulos, and G. Berkenblit, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet Lond Engl, vol.141, issue.6, pp.837-853, 1998.

J. S. Skyler, R. Bergenstal, and R. O. Bonow, Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association, Diabetes Care, vol.32, issue.1, pp.187-192, 2009.

R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. Neil, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, vol.359, issue.15, pp.1577-1589, 2008.

G. Cheng, C. Huang, H. Deng, and H. Wang, Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies, Intern Med J, vol.42, issue.5, pp.484-491, 2012.

G. J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol, vol.5, issue.1, pp.70284-70286, 2006.

T. Cukierman, H. C. Gerstein, and J. D. Williamson, Cognitive decline and dementia in diabetessystematic overview of prospective observational studies, Diabetologia, vol.48, issue.12, pp.2460-2469, 2005.

A. J. Sinclair, R. Hillson, and A. J. Bayer, National Expert Working Group. Diabetes and dementia in older people: a Best Clinical Practice Statement by a multidisciplinary National Expert Working Group, Diabet Med J Br Diabet Assoc, vol.31, issue.9, pp.1024-1031, 2014.

J. Doucet, L. Floch, J. Bauduceau, B. Verny, C. et al., GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion, Diabetes Metab, vol.38, issue.6, pp.523-530, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00931890

M. Buysschaert, L. Bordier, and B. Bauduceau, La dysfonction cognitive chez le diabétique âgé et ses causes : que nous apprend en plus la littérature récente ? HttpwwwemPremiumcomdatarevues19572557v9i1S1957255715300109, 2015.

B. Cholerton, L. D. Baker, and S. Craft, Insulin, cognition, and dementia, Eur J Pharmacol, vol.719, issue.13, pp.170-179, 2013.

P. K. Crane, R. Walker, and R. A. Hubbard, Glucose Levels and Risk of Dementia, N Engl J Med, vol.369, issue.6, pp.540-548, 2013.

H. B. Mehta, V. Mehta, and J. S. Goodwin, Association of Hypoglycemia With Subsequent Dementia in Older Patients With Type 2 Diabetes Mellitus, J Gerontol A Biol Sci Med Sci, 2016.

K. Yaffe, C. M. Falvey, and N. Hamilton, Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus, JAMA Intern Med, vol.173, issue.14, pp.1300-1306, 2013.

J. S. Skyler, R. Bergenstal, and R. O. Bonow, Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials, Circulation, vol.119, issue.2, pp.351-357, 2009.

, Haute Autorité de Santé-Stratégie médicamenteuse du contrôle glycémique du diabète de type 2, 2017.

D. Graillot, V. Quipourt, B. Bouillet, J. Petit, and P. Manckoundia, Diabète de type 2 chez le sujet âgé : quelles spécificités ? HttpwwwemPremiumcomdatarevues02488663v33i10S0248866312005358, 2012.

D. M. Tessier, . Lassmann-vague, and . Vjr, Diabetes and education in the elderly, Diabetes Metab, vol.33, issue.1, pp.75-78, 2007.

C. Szekely, S. Dekimeche, and C. Berthier, Quel régime chez le sujet âgé ? HttpwwwemPremiumcomdatarevues1957255700030004370, 2009.

U. M. Vischer, L. Perrenoud, C. Genet, S. Ardigo, Y. Registe-rameau et al., The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments, Diabet Med J Br Diabet Assoc, vol.27, issue.8, pp.918-924, 2010.

J. M. Bauer, M. J. Kaiser, P. Anthony, Y. Guigoz, and C. C. Sieber, The Mini Nutritional Assessment-its history, today's practice, and future perspectives, Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr, vol.23, issue.4, pp.388-396, 2008.

, Société Française de Gériatrie et Gérontologie > Mise en ligne du site Ateliers cuisine, 2017.

A. J. Sinclair, G. Paolisso, and M. Castro, European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary, Diabetes Metab, vol.37, issue.3, pp.27-38, 2011.

S. E. Inzucchi, R. M. Bergenstal, and J. B. Buse, Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetologia, vol.55, issue.6, pp.1577-1596, 2012.

F. Gregorio, F. Ambrosi, P. Filipponi, S. Manfrini, and I. Testa, Is metformin safe enough for ageing type 2 diabetic patients?, Diabetes Metab, vol.22, issue.1, pp.43-50, 1996.

F. Kajbaf and J. Lalau, Le traitement par metformine dans l'insuffisance rénale chronique chez le patient diabétique : une revue des recommandations et des prises de position à travers le monde. Httpwwwem-Premiumcomdatarevues19572557v8i2S1957255714707461, 2014.

A. Sinclair, J. E. Morley, and L. Rodriguez-mañas, Diabetes Mellitus in Older People: Position Statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes, J Am Med Dir Assoc, vol.13, issue.6, pp.497-502, 2012.

G. D. Braatvedt, A. J. Sykes, Z. Panossian, and D. Mcneill, The clinical course of patients with type 2 diabetes presenting to the hospital with sulfonylurea-induced hypoglycemia, Diabetes Technol Ther, vol.16, issue.10, pp.661-666, 2014.

L. J. Scott, Repaglinide: a review of its use in type 2 diabetes mellitus, Drugs, vol.72, issue.2, pp.249-272, 2012.

O. J. Phung, J. M. Scholle, M. Talwar, and C. I. Coleman, Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes, JAMA, vol.303, issue.14, pp.1410-1418, 2010.

A. Schweizer, S. Dejager, and E. Bosi, Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial, Diabetes Obes Metab, vol.11, issue.8, pp.804-812, 2009.

P. Hartley, Y. Shentu, and P. Betz-schiff, Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial, Drugs Aging, vol.32, issue.6, pp.469-476, 2015.

B. Bauduceau, L. Bordier, and J. Doucet, Les analogues lents de l'insuline : une aide pour l'insulinothérapie des sujets âgés. HttpwwwemPremiumcomdatarevues19572557v8i3S195725571470803X, 2014.
DOI : 10.1016/s1957-2557(14)70803-x

P. Lee, A. Chang, C. Blaum, A. Vlajnic, L. Gao et al., Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis, J Am Geriatr Soc, vol.60, issue.1, pp.51-59, 2012.

A. J. Garber, P. Clauson, C. B. Pedersen, and K. Kølendorf, Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials, J Am Geriatr Soc, vol.55, issue.11, pp.1735-1740, 2007.

I. Bourdel-marchasson, B. Dubroca, G. Manciet, A. Decamps, J. P. Emeriau et al., Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey, J Am Geriatr Soc, vol.45, issue.3, pp.295-301, 1997.

M. T. Schram, C. A. Baan, and F. Pouwer, Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium, Curr Diabetes Rev, vol.5, issue.2, pp.112-119, 2009.

I. Bourdel-marchasson, A. Tulon, and M. Erpelding, La qualité de vie des diabétiques de type 2 vivant en France métropolitaine : de multiples facteurs associés, Bull Epidemiol Hebd, pp.15-20, 2007.

C. Jenkinson, R. Layte, and D. Jenkinson, A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?, J Public Health Med, vol.19, issue.2, pp.179-186, 1997.

N. Laiteerapong, A. J. Karter, and J. Y. Liu, Correlates of quality of life in older adults with diabetes: the diabetes & aging study, Diabetes Care, vol.34, issue.8, pp.1749-1753, 2011.

D. Simon, P. De-pablos-velasco, and K. G. Parhofer, Hypoglycaemic episodes in patients with type 2 diabetes-risk factors and associations with patient-reported outcomes: The PANORAMA Study, Diabetes Metab, vol.41, issue.6, pp.470-479, 2015.

C. Bradley and D. S. Gamsu, Guidelines for encouraging psychological well-being: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes, Diabet Med J Br Diabet Assoc, vol.11, issue.5, pp.510-516, 1994.

A. Villez and . Ehpad, NURSING HOMES: PATTERN CRISIS. Gérontologie Société, vol.30, issue.4, pp.169-184, 2008.

L. N°, , 2002.

S. Volant, 693 000 résidents en établissements d'hébergement pour personnes âgées en, Etudes et résultats, issue.899, 2011.

, La clientèle des établissements d'hébergement pour personnes âgées-Situation au 31 décembre 2003-er485, 2017.

P. Lang, J. Proust, T. Vogel, and R. Aspinall, Saurons-nous jamais ce qui provoque le vieillissement ? Httpwwwem-Premiumcomdatarevues16274830v13i78S1627483013000639, 2013.
DOI : 10.1016/j.npg.2013.03.008

P. O. Lang, Le processus de fragilité : que comprendre de la physiopathologie ? HttpwwwemPremiumcomdatarevues16274830v13i73S1627483012001250, 2013.
DOI : 10.1016/j.npg.2012.08.002

Y. Rolland, A. Benetos, and A. Gentric, La fragilité de la personne âgée : un consensus bref de la Société française de gériatrie et gérontologie, Gériatrie Psychol Neuropsychiatr Vieil, vol.9, issue.4, pp.387-390, 2011.

, Haute Autorité de Santé-Comment repérer la fragilité en soins ambulatoires ?, 2017.

S. Volant, offre en établissements d'hébergement pour personnes âgées en, Études Résultats Drees, vol.877, 2011.

L. Calvet and N. Pradines, État de santé et dépendance des personnes âgées en institution ou à domicile-Études et résultats-Ministère des Affaires sociales et de la Santé, 2017.

Y. Makdessi, N. Pradines, and E. En, les résidents les plus dépendants souffrent davantage de pathologies aiguës-Études et résultats-Ministère des Affaires sociales et de la Santé, 2017.

A. Atramont, A. Rigault, S. Chevalier, G. Leblanc, A. Fagot-campagna et al., pathologies et mortalité des résidents en établissements d'hébergement pour personnes âgées dépendantes (Ehpad)

J. Perrin-haynes, J. Chazal, C. Chantel, and I. Falinower, Les personnes âgées en institution, Doss Solidar Santé DRESS, issue.22

M. Lilamand, E. Kelaiditi, L. Demougeot, Y. Rolland, B. Vellas et al., The Mini Nutritional Assessment-Short Form and mortality in nursing home residents-results from the INCUR study, J Nutr Health Aging, vol.19, issue.4, pp.383-388, 2015.

M. J. Kaiser, J. M. Bauer, and C. Ramsch, Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status, J Nutr Health Aging, vol.13, issue.9, pp.782-788, 2009.

K. Szczerbioska, E. Topinková, and P. Brzyski, The characteristics of diabetic residents in European nursing homes: results from the SHELTER study, J Am Med Dir Assoc, vol.16, issue.4, pp.334-340, 2015.

D. S. Budnitz, M. C. Lovegrove, N. Shehab, and C. L. Richards, Emergency hospitalizations for adverse drug events in older Americans, N Engl J Med, vol.365, issue.21, pp.2002-2012, 2011.

C. A. Newton, S. Adeel, and S. Sadeghi-yarandi, Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study, J Am Med Dir Assoc, vol.14, issue.11, pp.842-846, 2013.

S. B. Dybicz, S. Thompson, S. Molotsky, and B. Stuart, Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents, Am J Geriatr Pharmacother, vol.9, issue.4, pp.212-223, 2011.

A. J. Green, K. M. Fox, S. Grandy, . Shield-study, and . Group, Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus, Diabetes Res Clin Pract, vol.96, issue.3, pp.313-318, 2012.

P. De-souto-barreto, C. Sanz, B. Vellas, M. Lapeyre-mestre, and Y. Rolland, Drug treatment for diabetes in nursing home residents, Diabet Med J Br Diabet Assoc, vol.31, issue.5, pp.570-576, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01061656

A. M. Abbatecola, M. Bo, and M. Barbagallo, Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study, J Am Med Dir Assoc, vol.16, issue.4, p.349, 2015.

K. L. Lapane, B. M. Jesdale, C. E. Dubé, C. B. Pimentel, and S. N. Rajpathak, Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus, Diabetes Res Clin Pract, vol.109, issue.2, pp.411-419, 2015.

K. L. Davis, W. Wei, J. L. Meyers, B. S. Kilpatrick, and N. Pandya, Association between different hemoglobin A1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus, J Am Med Dir Assoc, vol.15, issue.10, pp.757-762, 2014.

B. Bouillet, G. Vaillant, and J. Petit, Are elderly patients with diabetes being overtreated in French long-term-care homes?, Diabetes Metab, vol.36, issue.4, pp.272-277, 2010.

C. T. Thorpe, W. F. Gellad, and C. B. Good, Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia, Diabetes Care, vol.38, issue.4, pp.588-595, 2015.

P. Sjöblom, A. Null, and U. Löfgren, Can diabetes medication be reduced in elderly patients? An observational study of diabetes drug withdrawal in nursing home patients with tight glycaemic control, Diabetes Res Clin Pract, vol.82, issue.2, pp.197-202, 2008.

A. F. Brown, C. M. Mangione, D. Saliba, and C. A. Sarkisian, California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus, J Am Geriatr Soc, vol.51, issue.5, pp.265-280, 2003.

, Association AD. Standards of Medical Care in Diabetes-2014, Diabetes Care, vol.37, 2014.

M. N. Munshi, H. Florez, and E. S. Huang, Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association, Diabetes Care, vol.39, issue.2, pp.308-318, 2016.

A. Benetos, J. Novella, and B. Guerci, Pragmatic diabetes management in nursing homes: individual care plan, J Am Med Dir Assoc, vol.14, issue.11, pp.791-800, 2013.
DOI : 10.1016/j.jamda.2013.08.003

S. E. Inzucchi, R. M. Bergenstal, and J. B. Buse, Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, vol.38, issue.1, pp.140-149, 2015.

V. Coutton, Évaluer la dépendance à l'aide de groupes iso-ressources (GIR):une tentative en France avec la grille aggir, Gérontologie Société, vol.24, issue.4, pp.111-129, 2009.
DOI : 10.3917/gs.099.0111

S. L. Aspinall, X. Zhao, and T. P. Semla, Epidemiology of drug-disease interactions in older veteran nursing home residents, J Am Geriatr Soc, vol.63, issue.1, pp.77-84, 2015.

S. Bucher, H. Panjo, A. -. Salameh, and A. , Relationship between achieved personalized glycaemic targets and monitoring of clinical events in elderly diabetic patients, Diabetes Metab, vol.43, issue.1, pp.59-68, 2017.

U. Ntoessafre, Au murs de ces quatre demières sena!Ms, y a-t-11 eu des moments où vous vous êtes senti( e) débordant( e) d'énergie ?

.. .. Très,

. .. Rarement·····················,

, Au cours de ces quatre dernières semaines, y a-Hl eu des moments où vous vous ères senti{ e) triste et clépri!né( e) ? (USEZ, ES OIOIX DE RiPoNSES SBILEMENrSI NÉCESSAIRE

. .. Quelquefois,

. .. Rarement,

.. .. Ou-jamais,

, Au cours de ces quatre dernières semaines, y .-t-il eu des moments où voCre état de santé. physique ou émotioo1nel, vous a gêné( e) dans votre vie sociale et vos relations avec les autres, votre famille, vos amis

(. Usez and L. Oioix-de-riponses,

.. .. Très,

. .. Quelque(ols,

. .. Rarement,

.. .. Ou-jamais, , vol.5, p.4

. .. Sf-u.2?-s, , 2006.